Literature DB >> 10063321

Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation.

J H Ahn1, J H Lee, K H Lee, W K Kim, J S Lee, H Bahng, H Y Jung, Y S Kim, O Kim, S H Kim.   

Abstract

Cytomegalovirus(CMV) disease is a major cause of morbidity and mortality in immunocompromised patients. CMV enteritis should be considered when nausea and vomiting continue 3 to 4 weeks after bone marrow transplantation(BMT). The treatment of CMV enteritis is not well established. We report a CMV duodenitis patient following allogenic bone marrow transplantation. The patient had prolonged nausea and vomiting for 5 weeks after bone marrow transplantation and CMV duodenitis was diagnosed by the gastroduodenoscopic mucosal biopsy which showed cytomegalic cells. Ganciclovir treatment for 3 weeks resulted in the resolution of symptoms and promoted healing of the lesion. The patient was free of CMV infection until 288 days after allogenic BMT without maintenance ganciclovir treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10063321      PMCID: PMC4531909          DOI: 10.3904/kjim.1999.14.1.91

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  10 in total

Review 1.  Intestinal and hepatic complications of human bone marrow transplantation. Part II.

Authors:  G B McDonald; H M Shulman; K M Sullivan; G D Spencer
Journal:  Gastroenterology       Date:  1986-03       Impact factor: 22.682

2.  Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods.

Authors:  R C Hackman; J L Wolford; C A Gleaves; D Myerson; M D Beauchamp; J D Meyers; G B McDonald
Journal:  Transplantation       Date:  1994-01       Impact factor: 4.939

3.  Cytomegalovirus infection of the alimentary canal: radiologic findings with pathologic correlation.

Authors:  H S Teixidor; C L Honig; E Norsoph; S Albert; J A Mouradian; J P Whalen
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

4.  A prospective study of unexplained nausea and vomiting after marrow transplantation.

Authors:  G D Spencer; R C Hackman; G B McDonald; D E Amos; B A Cunningham; J D Meyers; E D Thomas
Journal:  Transplantation       Date:  1986-12       Impact factor: 4.939

5.  Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial.

Authors:  E C Reed; J L Wolford; K J Kopecky; K E Lilleby; P S Dandliker; J L Todaro; G B McDonald; J D Meyers
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

6.  Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS.

Authors:  D T Dieterich; A Chachoua; F Lafleur; C Worrell
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations.

Authors:  J L Mayoral; C M Loeffler; C G Fasola; M A Kramer; W J Orrom; A J Matas; J S Najarian; D L Dunn
Journal:  Arch Surg       Date:  1991-02

Review 8.  Gastrointestinal cytomegalovirus disease.

Authors:  R W Goodgame
Journal:  Ann Intern Med       Date:  1993-11-01       Impact factor: 25.391

9.  Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea.

Authors:  H Einsele; G Ehninger; H Hebart; P Weber; S Dette; H Link; H P Horny; V Meuter; S Wagner; H D Waller
Journal:  Bone Marrow Transplant       Date:  1994-12       Impact factor: 5.483

Review 10.  Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS.

Authors:  F S Buckner; C Pomeroy
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.